VGLS

VG Life Sciences Inc. [VGLS] Stock Forecast

Q: What is VG Life Sciences Inc. stock symbol ?

VG Life Sciences Inc. is a US stock, located in Santa barbara of Ca and trading under the symbol VGLS

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

VGLS Stock Summary

Does not have any significance market cap ($21.1K)

VGLS has less than 1 year of cash runway

In the News

VGLS Financial details

Company Rating

Neutral

Market Cap

21.1K

Income

-2.53M

Revenue

Book val./share

Cash/share

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

19 Nov 2015

P/E

Forward P/E

PEG

P/S

P/B

P/C

P/FCF

-0.03

Quick Ratio

0.01

Current Ratio

0.04

Debt / Equity

LT Debt / Equity

EPS (TTM)

-0

EPS next Y

EPS next Q

EPS this Y

-150%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

EPS Q/Q

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

-676%

ROE

173%

ROC

0.92%

Gross Margin

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1.0E-6-1.0E-4

52W High

52W Low

RSI

49.3

Rel Volume

0.67

Avg Volume

25.22M

Volume

17M

Perf Week

Perf Month

Perf Quarter

Perf Half Y

-50%

Beta

74.091

Volatility

0%, 0%

Prev Close

-50%

Price

0.00005

Change

VGLS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0	0	0	0
Net income per share	0	-0.01	0	0	0
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	-0.06	-0.06	0	0	0
Tangible book value per share	-0.06	-0.05	0	0	0
Share holders equity per share	-0.06	-0.06	0	0	0
Interest debt per share	0.03	0.03	0	0	0
Market cap	766.57K	789.63K	1.2M	1.09M	18.7K
Enterprise value	4.64M	5.44M	3.81M	3.27M	0
P/E ratio	-2.86	-0.54	-0.97	0.52	-0.01
Price to sales ratio	0	0	0	0	0
POCF ratio	0	0	0	-42.77	-0.92
PFCF ratio	0	0	0	-42.77	-0.92
P/B Ratio	-0.09	-0.09	-0.22	-0.24	0
PTB ratio	-0.09	-0.09	-0.22	-0.24	0
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	134.84	-4.59	-3.27	-137.8	0
EV to operating cash flow	0	0	0	-128.09	0
EV to free cash flow	0	0	0	-128.09	0
Earnings yield	-0.35	-1.84	-1.03	1.93	-135.3
Free cash flow yield	0	0	0	-0.02	-1.09
Debt to equity	-0.47	-0.5	-0.48	-0.47	0
Debt to assets	0	0	0	0	0
Net debt to EBITDA	112.56	-3.92	-2.24	-91.79	0
Current ratio	0	0	0	0	0
Interest coverage	0.11	-4.42	-15.38	-0.48	-0.3
Income quality	0	0	0	-0.01	0.01
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	0.05	0.11	0.01	0	0
ROIC	-0.01	0.26	0.41	0.01	0
Return on tangible assets	0	0	0	0	0
Graham Net	-0.06	-0.05	0	0	0
Working capital	-7.72M	-8.81M	-5.01M	-4.62M	0
Tangible asset value	-7.72M	-8.81M	-5.01M	-4.62M	0
Net current asset value	-7.72M	-8.81M	-5.01M	-4.62M	0
Invested capital	-0.47	-0.5	-0.48	-0.47	0
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.03	0.16	0.23	-0.46	0
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0	0	0	0
Net income per share	0	0	0	0	0
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	0	0	0	0	0
Tangible book value per share	0	0	0	0	0
Share holders equity per share	0	0	0	0	0
Interest debt per share	0	0	0	0	0
Market cap	1.75M	928.91K	1.75M	1.87M	21.09K
Enterprise value	3.93M	3.08M	3.94M	3.98M	0
P/E ratio	-8.38	-14.49	-67.66	-144.57	0
Price to sales ratio	0	0	0	0	0
POCF ratio	-99.3	-228.06	-196	-1.1K	-3.73
PFCF ratio	-99.3	-228.06	-196	-1.1K	-3.73
P/B Ratio	-0.38	-0.2	-0.38	-0.41	0
PTB ratio	-0.38	-0.2	-0.38	-0.41	0
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	-223.27	-756.69	-442.38	-2.34K	0
EV to operating cash flow	-223.31	-756.13	-442.38	-2.34K	0
EV to free cash flow	-223.31	-756.13	-442.38	-2.34K	0
Earnings yield	-0.03	-0.02	0	0	-118.74
Free cash flow yield	-0.01	0	-0.01	0	-0.27
Debt to equity	-0.47	-0.47	-0.47	-0.46	0
Debt to assets	0	0	0	0	0
Net debt to EBITDA	-123.99	-528.45	-246.37	-1.24K	0
Current ratio	0	0	0	0	0
Interest coverage	-51.89	-4.09	-0.89	-4.08	-0.1
Income quality	0.34	0.25	1.38	0.53	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	0	0	0	0	0
ROIC	0.01	0	0	0	0
Return on tangible assets	0	0	0	0	0
Graham Net	0	0	0	0	0
Working capital	-4.62M	-4.6M	-4.64M	-4.56M	0
Tangible asset value	-4.62M	-4.6M	-4.64M	-4.56M	0
Net current asset value	-4.62M	-4.6M	-4.64M	-4.56M	0
Invested capital	-0.47	-0.47	-0.47	-0.46	0
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.01	0	0	0	0
Capex per share	0	0	0	0	0

VGLS Frequently Asked Questions

What is VG Life Sciences Inc. stock symbol ?

VG Life Sciences Inc. is a US stock , located in Santa barbara of Ca and trading under the symbol VGLS

What is VG Life Sciences Inc. stock quote today ?

VG Life Sciences Inc. stock price is $0.00005 today.

Is VG Life Sciences Inc. stock public?

Yes, VG Life Sciences Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Same Price Range

Similar Market Cap

Company Profile

Volume Average 25.22M
Market Capitalization 21.1K
Employee 1
CEO Mr. Haig Keledjian
Headquarters Santa Barbara,CA,US
IPO Date 1999-12-07
Website https://www.vglifesciences.com

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.